-
EP0756605
European procedure
Extract from the Register of European Patents
EP About this file: EP0756605
| EP0756605 - PEPTIDES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF AUTO-IMMUNE DISEASES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.06.2000 Database last updated on 13.11.2024 | Most recent event Tooltip | 09.06.2000 | No opposition filed within time limit | published on 26.07.2000 [2000/30] | Applicant(s) | For all designated states Wildner, Gerhild Rupprechtstrasse 8a 80636 München / DE | For all designated states Thurau, Stephan Sendlinger Strasse 28 80331 München / DE | [1997/06] | Inventor(s) | 01 /
see applicant ... | [1997/06] | Representative(s) | Wibbelmann, Jobst Wuesthoff & Wuesthoff Patentanwälte und Rechtsanwalt PartG mbB Schweigerstrasse 2 81541 München / DE | [N/P] |
| Former [1997/06] | Wibbelmann, Jobst, Dr., Dipl.-Chem. Wuesthoff & Wuesthoff, Patent- und Rechtsanwälte, Schweigerstrasse 2 81541 München / DE | Application number, filing date | 95918582.8 | 21.04.1995 | [1997/06] | WO1995EP01512 | Priority number, date | DE19944413938 | 21.04.1994 Original published format: DE 4413938 | [1997/06] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO9529194 | Date: | 02.11.1995 | Language: | DE | [1995/47] | Type: | A1 Application with search report | No.: | EP0756605 | Date: | 05.02.1997 | Language: | DE | The application published by WIPO in one of the EPO official languages on 02.11.1995 takes the place of the publication of the European patent application. | [1997/06] | Type: | B1 Patent specification | No.: | EP0756605 | Date: | 11.08.1999 | Language: | DE | [1999/32] | Search report(s) | International search report - published on: | EP | 02.11.1995 | Classification | IPC: | C07K14/74, C07K14/47, C07K7/08, A61K38/10, A61K38/17 | [1997/06] | CPC: |
C07K14/70539 (EP,US);
A61P1/04 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
| Designated contracting states | CH, DE, ES, FR, GB, IT, LI [1997/06] | Title | German: | PEPTIDE ALS THERAPEUTIKUM FÜR AUTOIMMUNERKRANKUNGEN | [1997/06] | English: | PEPTIDES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF AUTO-IMMUNE DISEASES | [1997/06] | French: | PEPTIDES UTILISE COMME AGENTS THERAPEUTIQUES DANS LE TRAITEMENT DE MALADIES AUTO-IMMUNES | [1997/06] | Entry into regional phase | 11.10.1996 | National basic fee paid | 11.10.1996 | Designation fee(s) paid | 11.10.1996 | Examination fee paid | Examination procedure | 17.11.1995 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 11.10.1996 | Examination requested [1997/06] | 11.08.1997 | Despatch of a communication from the examining division (Time limit: M04) | 17.12.1997 | Reply to a communication from the examining division | 11.03.1998 | Despatch of a communication from the examining division (Time limit: M04) | 10.07.1998 | Reply to a communication from the examining division | 11.09.1998 | Despatch of communication of intention to grant (Approval: Yes) | 14.01.1999 | Communication of intention to grant the patent | 30.03.1999 | Fee for grant paid | 30.03.1999 | Fee for publishing/printing paid | Opposition(s) | 12.05.2000 | No opposition filed within time limit [2000/30] | Fees paid | Renewal fee | 16.04.1997 | Renewal fee patent year 03 | 17.04.1998 | Renewal fee patent year 04 | 16.04.1999 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9404171 (HARVARD COLLEGE [US]) [X] 1-4,6,7,16 * Siehe S. 45; S. 83-85: Seq ID Nr. 112-118; S. 106-107:SEQ ID Nr. 197-200; Anspr.1-4,11,17 *; | [X]WO9404557 (HARVARD COLLEGE [US]) [X] 1-4,6,7,16 * page 41; claims 1-4,10,12-15 * | [DA] - S.R.THURAU U.A., "Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide", J.AUTOIMMUNITY, vol. 4, no. 3, pages 507 - 516 [DA] 1-17 | [PX] - G.WILDNER U.A., "Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide...", EUR.J.IMMUNOL., vol. 24, no. 11, pages 2579 - 2585 [PX] 1-17 * the whole document * |